Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | XRAY DENTSPLY SIRONA Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $10.38 -0.8% | $16.41 +1.9% |
| StockIQ Score | 44D Weak Risk: High | 35F Weak Risk: High |
| Technical | 21F | 13F |
| Fundamental | 31F | 35F |
| Growth | 60C+ | 50C- |
| Fair Value | 50C- | 38F |
| News | 100A+ | 50C- |
| Quality | 42D | 50C- |
| Risk | 34F | 40D |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
DENTSPLY SIRONA (XRAY) outperforms Ascentage Pharma (AAPG) in growth and valuation, scoring 60 and 50 respectively, compared to AAPG’s 50 and 38. However, AAPG has a slightly higher fundamental score (35 vs. 31) and a better technical score (13 vs. 21). Both carry a "WEAK" rating, but XRAY’s stronger growth and valuation scores make it the better performer in those areas.
